Mark Atlas

816 total citations
23 papers, 443 citations indexed

About

Mark Atlas is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark Atlas has authored 23 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Genetics and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark Atlas's work include Glioma Diagnosis and Treatment (7 papers), Innovations in Medical Education (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Mark Atlas is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Innovations in Medical Education (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Mark Atlas collaborates with scholars based in United States, Canada and United Kingdom. Mark Atlas's co-authors include Richard Florida, Sharon L. Gardner, Jonathan L. Finlay, Robert I. Parker, Jeffrey C. Allen, John A. Boockvar, Marc Symons, Rosamaria Ruggieri, Girish Dhall and Richard Sposto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mark Atlas

23 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Atlas United States	13	129	121	98	87	57	23	443
Fábio Morato de Oliveira Brazil	15	187 1.4×	121 1.0×	91 0.9×	25 0.3×	56 1.0×	45	462
Jessie Sullivan United States	5	98 0.8×	73 0.6×	103 1.1×	28 0.3×	44 0.8×	6	606
E. Pittermann Austria	8	80 0.6×	127 1.0×	253 2.6×	48 0.6×	72 1.3×	34	398
Heather A. Bradeen United States	6	64 0.5×	217 1.8×	262 2.7×	52 0.6×	23 0.4×	7	400
Wolfgang Langer Germany	8	74 0.6×	70 0.6×	70 0.7×	38 0.4×	67 1.2×	22	318
Eri Matsuki Japan	11	61 0.5×	127 1.0×	153 1.6×	44 0.5×	134 2.4×	41	492
Güldane Cengiz Seval Türkiye	11	144 1.1×	42 0.3×	170 1.7×	74 0.9×	26 0.5×	59	411
Daniela Hoehn United States	15	276 2.1×	188 1.6×	257 2.6×	78 0.9×	219 3.8×	50	674
K. Tricker United Kingdom	11	306 2.4×	47 0.4×	44 0.4×	64 0.7×	100 1.8×	13	704
Nidale Tarek United States	11	120 0.9×	28 0.2×	124 1.3×	61 0.7×	13 0.2×	27	479

Countries citing papers authored by Mark Atlas

Since Specialization

Citations

This map shows the geographic impact of Mark Atlas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Atlas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Atlas more than expected).

Fields of papers citing papers by Mark Atlas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Atlas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Atlas. The network helps show where Mark Atlas may publish in the future.

Co-authorship network of co-authors of Mark Atlas

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Atlas. A scholar is included among the top collaborators of Mark Atlas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Atlas. Mark Atlas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hanson, Derek, et al.. (2024). A phase 1 study of mebendazole with bevacizumab and irinotecan in high‐grade gliomas. Pediatric Blood & Cancer. 71(4). e30874–e30874. 3 indexed citations

Mink, Richard, Alan Schwartz, John D. Mahan, et al.. (2024). Level of Supervision for the Entrustable Professional Activities Common to General Pediatrics and the Subspecialties Decreases from Residency to Fellowship. Academic Pediatrics. 24(7). 1025–1030. 1 indexed citations

Redner, Arlene, et al.. (2023). A comprehensive strategy to address shortage of Erwinia asparaginase in pediatric acute lymphoblastic leukemia. Expert Review of Clinical Pharmacology. 16(8). 763–769. 1 indexed citations

Atlas, Mark, et al.. (2019). Delivering Challenging News: An Illness-Trajectory Communication Curriculum for Multispecialty Oncology Residents and Fellows. SHILAP Revista de lepidopterología. 15. 10819–10819. 27 indexed citations

Hanson, Derek, et al.. (2017). Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors. Molecular Medicine. 23(1). 50–56. 66 indexed citations

Goldman, Stewart, Aradhana Kaushal, John Glod, et al.. (2016). EPT-16A PHASE 1 TRIAL OF LENALIDOMIDE PLUS RADIOTHERAPY IN CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMAS OR HIGH-GRADE GLIOMAS. Neuro-Oncology. 18(suppl 3). iii27.2–iii27. 1 indexed citations

Kesselheim, Jennifer C., Mark Atlas, Denise M. Adams, et al.. (2014). Humanism and professionalism education for pediatric hematology‐oncology fellows: A model for pediatric subspecialty training. Pediatric Blood & Cancer. 62(2). 335–340. 17 indexed citations

Zaky, Wafik, Girish Dhall, Lingyun Ji, et al.. (2013). Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly‐diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience. Pediatric Blood & Cancer. 61(1). 95–101. 65 indexed citations

Dhall, Girish, Juliane Grimm, Floyd H. Gilles, et al.. (2011). Outcome of infants and young children with newly diagnosed medulloblastoma treated on Head Start III protocol.. Journal of Clinical Oncology. 29(15_suppl). 2011–2011. 27 indexed citations

10.

Goyal, Rakesh K., Yan Lin, Kirk R. Schultz, et al.. (2010). Tumor Necrosis Factor-α Gene Polymorphisms Are Associated with Severity of Acute Graft-Versus-Host Disease Following Matched Unrelated Donor Bone Marrow Transplantation in Children: A Pediatric Blood and Marrow Transplant Consortium Study. Biology of Blood and Marrow Transplantation. 16(7). 927–936.e1. 16 indexed citations

11.

Lakshminarayanan, Sonali, et al.. (2009). Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution. Pediatric Transplantation. 14(5). 618–621. 8 indexed citations

12.

Redner, Arlene, et al.. (2009). Solitary Extramedullary Plasmacytoma of the Vocal Cord in an Adolescent. Journal of Clinical Oncology. 27(35). e244–e247. 14 indexed citations

13.

Shende, Ashok, et al.. (2008). Transient Myeloproliferative Disorder in Neonates With and Without Down Syndrome. Journal of Pediatric Hematology/Oncology. 30(11). 860–864. 20 indexed citations

14.

Fangusaro, Jason, Rima Jubran, Jeffrey C. Allen, et al.. (2006). Brainstem primitive neuroectodermal tumors (bstPNET): Results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue. Pediatric Blood & Cancer. 50(3). 715–717. 16 indexed citations

15.

Atlas, Mark, Gregory A. Yanik, & Rakesh K. Goyal. (2006). Tacrolimus Versus Cyclosporine for Graft-Versus-Host Disease Prophylaxis in Pediatric Patients Undergoing Matched Unrelated Donor Hematopoietic Stem Cell Transplants. A Pediatric Blood and Marrow Transplant Consortium Study... Blood. 108(11). 2883–2883. 1 indexed citations

16.

Parker, Robert I., et al.. (2002). Randomized Trial of High-Dose Methylprednisolone Versus Intravenous Immunoglobulin for the Treatment of Acute Idiopathic Thrombocytopenic Purpura in Children. Journal of Pediatric Hematology/Oncology. 24(7). 540–544. 35 indexed citations

17.

Atlas, Mark, et al.. (2001). Randomized, Double-Blind, Crossover, Placebo-Controlled Trial of Intravenous Ondansetron for the Prevention of Intrathecal Chemotherapy-Induced Vomiting in Children. The American journal of pediatric hematology/oncology. 23(9). 578–581. 16 indexed citations

18.

Florida, Richard, et al.. (2001). What Makes Companies Green? Organizational and Geographic Factors in the Adoption of Environmental Practices. Economic Geography. 77(3). 209–209. 42 indexed citations

19.

Atlas, Mark, et al.. (2000). Metastatic Congenital Adrenocortical Carcinoma: A Case Report with Tumor Remission at 31/2 Years. The Journal of Clinical Endocrinology & Metabolism. 85(11). 3964–3967. 10 indexed citations

20.

Kletzel, Morris, et al.. (1997). Red Cell Depletion of Umbilical Cord Blood (UCB): Comparison Between Unmanipulated and Red Cell-Depleted UCB by Ficoll-Paque Density Gradient Separation. Journal of Hematotherapy. 6(3). 269–272. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact